Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2013
03/19/2013US8399000 Haemophilus influenzae type IV pili
03/19/2013US8398999 Chimeric, hybrid and tandem polypeptides of meningococcal NMB1870
03/19/2013US8398997 Polylysine positively charged backbone, oligoarginine branching group, hydroxypropylcellulose viscosity modifying agent; treating wrinkles, hyperhidrosis, neurologic pain, migraine headache, reducing muscle spasms, preventing or reducing acne
03/19/2013US8398996 Staphylococcus aureus proteins and nucleic acids
03/19/2013US8398990 Glucan-based vaccines
03/19/2013US8398986 ADP-ribosylating toxin from listeria monocytogenes
03/19/2013US8398984 Removal promoters and inhibitor for apoptosis cells in vivo
03/19/2013US8398982 Compositions and methods for the diagnosis and treatment of tumor
03/19/2013US8398972 Methods of treating dementia using a GM-CSF antagonist
03/19/2013US8398967 Particle formulations for use in pharmaceutical compositions
03/19/2013CA2705716C Novel rubella e1 envelope protein variants and their use in the detection of anti-rubella antibodies
03/19/2013CA2667814C Waxy wheat starch types having waxy proteins in granule
03/19/2013CA2594728C Maize cyclo1 gene and promoter
03/19/2013CA2551905C Nucleic acid encoding a novel prostaglandin receptor protein and methods of use thereof
03/19/2013CA2500248C Peptide derivative fusion inhibitors of hiv infection
03/19/2013CA2491907C Oncolytic virus replicating selectively in tumor cells
03/19/2013CA2481764C Plants with improved morphogenesis and method of constructing the same
03/19/2013CA2452767C Genetic recombinant ecarin and process for preparing the same
03/19/2013CA2440303C Wt1 modified peptide
03/19/2013CA2434364C Method for secretory production of glycoprotein having human-type sugar chain using plant cell
03/19/2013CA2429342C Promoters exhibiting endothelial cell specificity and methods of using same
03/19/2013CA2426172C Nucleic acid amplification controls
03/19/2013CA2416203C Dna sequences coding for a polyol carrier and use thereof, in particular for preparing transgenic plants
03/19/2013CA2354638C Expression of secreted human alpha-fetoprotein in transgenic animals
03/19/2013CA2311647C Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination
03/19/2013CA2195334C Compositions and methods for enhanced tumor cell immunity in vivo
03/19/2013CA1341635C Insect-resistant plants
03/19/2013CA1341634C Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humanin (virus hiv) leurs applications au diagnostic des infections dues acertains de ces virus et, le cas echeant, a la vaccination contre le sida
03/14/2013WO2013036861A1 Biocatalysts and methods for the synthesis of substituted lactams
03/14/2013WO2013036829A1 Treatment of th17 mediated inflammatory diseases
03/14/2013WO2013036756A1 Viable gram negative bacteria with reduced proteolytic activity lacking outer membrane agonists of tlr4/md-2
03/14/2013WO2013036721A1 Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
03/14/2013WO2013036636A1 Compositions and methods of treating cancer
03/14/2013WO2013036101A1 Rubber allergenic proteins and immunoassay derived thereof
03/14/2013WO2013036100A1 A method for regulating plastidial isoprenoid biosynthesis in hevea brasiliensis
03/14/2013WO2013034805A1 Neuroprotective cell-penetrating peptides
03/14/2013WO2013034795A1 Peptide secreted by lactobacillus plantarum with immunomodulating function
03/14/2013WO2013034749A1 Polypeptides targeting glycosylated muc2 proteins, methods of synthesis, their nucleic acids and uses thereof
03/14/2013WO2013034687A1 Avibacterium paragallinarum rtx toxin
03/14/2013WO2013034666A2 Novel pheromonal receptor of spodoptera littoralis (lepidoptera, noctuidae) and identification of natural ligand of said receptor and uses thereof
03/14/2013WO2013034116A1 Vascular endothelial myostatin mutant that mutates at atp binding sites
03/14/2013WO2013034106A1 Polypeptides having alpha-amylase activity and polynucleotides encoding same
03/14/2013WO2013034097A1 Polypeptides having glucoamylase activity and polynucleotides encoding same
03/14/2013WO2013034069A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013WO2013011184A3 Chimeric molecule useful in immunotherapy for leishmaniasis, which includes a fragment of the pfr1 protein of leishmania infantum with specific immunodominant epitopes
03/14/2013WO2013011056A3 Pathology biomarker assay
03/14/2013WO2013001285A3 Fmdv vp1 peptides
03/14/2013WO2012175676A3 Molecules specifically binding pancreatic beta cells biomarkers
03/14/2013WO2012173422A9 A conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereof
03/14/2013WO2012173390A3 Method for enhancing the production yield of human papillomavirus l1 protein
03/14/2013WO2012172346A3 Treating respiratory conditions
03/14/2013WO2012172344A3 Treating conditions associated with sepsis
03/14/2013WO2012170782A3 Production of post-translationally hydroxylated recombinant proteins in bacteria
03/14/2013WO2012150503A3 Glu-glp-1 dual agonist signaling-selective compounds
03/14/2013WO2012146171A9 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
03/14/2013WO2012144778A9 Surface-active collagen barrier membrane to which a peptide is bound
03/14/2013WO2012143477A3 Anticancer fusion protein
03/14/2013WO2012135177A3 Methods and compositions for cytomegalovirus il-10 protein
03/14/2013WO2012123959A3 Copolymer-1, process for preparation and analytical methods thereof
03/14/2013WO2012120535A3 A composition comprising highly purified chorionic gonadotropin, it's formulation and uses of the same
03/14/2013WO2012120532A3 Cyclic short chain pth analog peptides
03/14/2013WO2012115715A3 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use
03/14/2013US20130067620 Improved Compositions and Methods for Pathogen Control in Plants
03/14/2013US20130067608 Colon cancer targets and uses thereof
03/14/2013US20130067603 Sperm-specific cation channel, catsper4, and uses therefor
03/14/2013US20130066060 Gene for Identifying Individuals with Familial Dysautonomia
03/14/2013US20130066052 Ucp4
03/14/2013US20130066050 Chlamydomonas intraflagellar transport 88 (ift-88)
03/14/2013US20130066049 Hemostatic compositions
03/14/2013US20130066048 Methods of Obtaining Natural Products from the Comestible Fluids and Methods of Use
03/14/2013US20130066047 Red-shifted channelrhodopsins
03/14/2013US20130066046 General Method for Generating Ultra-High Affinity Binding Proteins
03/14/2013US20130065838 Sap variants and their use
03/14/2013US20130065829 Peptides and supported peptides for treating skin diseases
03/14/2013US20130065820 Synthetic myostatin peptide antagonists
03/14/2013US20130065819 Target of egr1 (toe1) polypeptides for inhibition of hiv
03/14/2013US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use
03/14/2013US20130065275 Serum-free mammalian cell culture medium, and uses thereof
03/14/2013US20130065272 Synthesis of Site Specifically-Linked Ubiquitin
03/14/2013US20130065258 Colorectal cancer marker galectin, method for analyzing galectin concentration in blood sample, and kit for detecting colorectal cancer marker galectin
03/14/2013US20130065250 Kit and Method for Detecting Porous Dental Hydroxyapatite
03/14/2013US20130065238 Syngap1 dysfunctions and uses thereof in diagnostic and therapeutic applications for mental retardation
03/14/2013US20130065235 Binding and functional assays that use the t1r3 receptor to screen for taste modulatory compounds
03/14/2013US20130064866 Pulmonary and nasal delivery of serum amyloid p
03/14/2013US20130064853 Parasite vaccine
03/14/2013US20130064846 Neisserial antigens
03/14/2013US20130064844 Non-splicing variants of gp350/220
03/14/2013US20130064842 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl)
03/14/2013US20130064841 Immunogenic compositions against human progastrin peptides
03/14/2013US20130064830 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
03/14/2013US20130064829 Antibodies Specific for Sclerostin and Methods for Increasing Bone Mineralization
03/14/2013US20130064827 Il-17 homologous polypeptides and thereapeutic uses thereof
03/14/2013US20130064813 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof
03/14/2013US20130064792 Therapy for influenza like illness
03/14/2013US20130064791 Interferon Analogs
03/14/2013US20130064788 Il-17 family cytokine compositions and uses
03/14/2013CA2848211A1 Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
03/14/2013CA2848118A1 Endostatin mutants with mutations at atp binding sites
03/14/2013CA2848117A1 Recombinant influenza virus highly expressing ha protein and preparation method and use thereof
03/14/2013CA2848056A1 Protein-containing adhesives, and manufacture and use thereof
1 ... 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 ... 2916